Does TIPRANAVIR Cause Neoplasm progression? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Neoplasm progression have been filed in association with TIPRANAVIR (Aptivus). This represents 2.2% of all adverse event reports for TIPRANAVIR.
9
Reports of Neoplasm progression with TIPRANAVIR
2.2%
of all TIPRANAVIR reports
0
Deaths
6
Hospitalizations
How Dangerous Is Neoplasm progression From TIPRANAVIR?
Of the 9 reports, 6 (66.7%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIPRANAVIR. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does TIPRANAVIR Cause?
Cholelithiasis (218)
Schizophrenia (217)
Nausea (216)
Pneumonia (216)
Vomiting (216)
Hypomania (151)
Hepatotoxicity (148)
Psychotic disorder (148)
Blood bilirubin increased (147)
Condition aggravated (147)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which TIPRANAVIR Alternatives Have Lower Neoplasm progression Risk?
TIPRANAVIR vs TIRBANIBULIN
TIPRANAVIR vs TIROFIBAN
TIPRANAVIR vs TIRZEPATIDE
TIPRANAVIR vs TISAGENLECLEUCEL
TIPRANAVIR vs TISLELIZUMAB